May 7, 2020 / 8:27 AM / a month ago

BRIEF-Dar Al-Shifa Pharmaceuticals Says April Sales Down 40% Due To COVID-19

May 7 (Reuters) - DAR AL-SHIFA PHARMACEUTICALS:

* Q1 SALES $17.2 MILLION

* APRIL SALES DOWN 40% DUE TO COVID-19

* DECREASE IN SALES WILL LEAD TO DECREASE IN LIQUIDITY FOR COMING MONTHS Source:(bit.ly/2YNkUIV) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below